Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
May 01, 2024 09:00 ET
|
Elevai Labs Inc.
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
MYOS Corporation to Present Mechanism of Action Data at the Experimental Biology Conference
February 23, 2015 07:30 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Feb 23, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Reports 2014 Third Quarter Results and Provides Business Update
November 14, 2014 10:30 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 14, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation to Announce Second Quarter 2014 Financial Results on August 14, 2014
August 07, 2014 08:05 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 7, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces Third Quarter Results;
November 07, 2013 08:25 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 7, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
MYOS to Study Synergistic Effects of Myostatin Inhibition on Testosterone-Mediated Muscle Growth; Brigham and Women's Hospital, a Teaching Affiliate of Harvard Medical School, to Conduct the Study
August 15, 2013 08:00 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 15, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
UPDATE: MYOS Reports Second Quarter 2013 Financial Results and Recent Key Operational Highlights
August 13, 2013 14:16 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 13, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
MYOS Reports Second Quarter 2013 Financial Results and Recent Key Operational Highlights
August 13, 2013 08:00 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 13, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
MYOS Signs Exclusive Supply Contract, Plans New Product R&D, With DIL
July 11, 2013 08:05 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jul 11, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of products that improve human muscle health...
MYOS to Initiate a New Clinical Study on MYO-T12; Company Plans to Introduce Muscle Health Products for Women
June 19, 2013 08:00 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jun 19, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of products that improve human muscle health...